Ok, starting to read up more on this company. So much stuff. LOL. A couple interesting tidbits....
The gross profit for the year ended May 31, 2017 was $17,297,533, compared to a gross profit of $5,977,428 in the same period of the prior year.
That's some growth 2016 to 2017. I can only imagine 2019!!
2018 Subsidiaries Jurisdiction of incorporation Ownership interest Pure Natures Wellness Inc. (o/a Aphria) Ontario, Canada 100% Aphria (Arizona) Inc. Arizona, United States 100% Cannan Growers Inc. British Columbia, Canada 100% Nuuvera Inc. Ontario, Canada 100% Nuuvera Holdings Ltd. Ontario, Canada 100% ARA – Avanti Rx Analytics Inc. Ontario, Canada 100% Avalon Pharmaceuticals Inc. Ontario, Canada 100% 2589671 Ontario Inc. Ontario, Canada 100% 2589674 Ontario Inc. Ontario, Canada 100% Nuuvera Israel Ltd. Tel Aviv, Israel 100% Nuuvera Deutschland GmbH Hamburg, Germany 100% FL-Group Genoa, Italy 100% Broken Coast Cannabis Ltd. British Columbia, Canada 99.86% Nuuvera Malta Ltd. Valletta, Malta 90% ASG Pharma Ltd. Valletta, Malta 90% 1974568 Ontario Ltd. Ontario, Canada 51% CannInvest Africa Ltd. South Africa 50%
The company has great planning ability it seems....
The Company currently has 300,000 square feet of licensed production space at Aphria One capable of producing 30,000 kgs annually. The Company allocated a portion of its space from the Part III expansion to mother and vegetative plants which will be required for the Part IV and Part V expansions, effectively lowering Aphria One’s functional capacity today to ensure an as efficient as possible running start to its Part IV growing operations. With the fully capitalized Part IV and Part V expansions, the Company will be poised to have over 1,000,000 sq. ft. of state-of-the-art greenhouse facility producing 110,000 kgs annually in January 2019.
Love this type of stuff....
The Company is installing a power co-generation plant that utilizes natural gas to generate is own electricity and as a by-product of this process, hot and cold water and CO2. This combined -cycle process will not only generate electricity to be used in the greenhouse to operate the lights and air conditioners, but also the hot and cold water produced will be employed to effectively control the temperature and humidity for the plants. The residual gas emissions created by this process will be directed through a catalytic converter to create CO2 which will be used during the growing cycle of the plants. At the same time, the Company installed state-of-the-art power switching in APHRIA 2018 ANNUAL REPORT MANAGEMENT’S DISCUSSION AND ANALYSIS 17 all equipment allowing it to switch power between the electrical grid and the power co-generation equipment at a moment’s notice to ensure it is constantly using the most cost effective energy available.
2017 to 2018...WOW. It is now LEGAL IN CANADA. Worthless? I say not.
The gross profit for the year ended May 31, 2018 was $40,887,('000s compared to $17,297 in the prior year. The increase in gross profit from the prior year is consistent with the Company’s much larger patient base over the prior year, the acquisition of Broken Coast, and the increase in the net fair value adjustments for biological assets as a result of the Company’s increased production levels.
Gross MArgins 110.8%. Say HUH?!?!
The Company recorded net income for the year ended May 31, 2018 of $29,448 or $0.18 per share as opposed to net income of $4,198 or $0.04 per share in the same period of the prior year.
Aphria has the following securities issued and outstanding, as at July 31, 2018: Presently outstanding
I give APHA a strong buy based on peer valuation, new laws, potential legalization around the World, medical breakthroughs and what I read so far about the company. Show me something truly bad.
Best of Luck in the coming weeks!
wook
Best of $RESULTS for Humanity, FDA Approval(s), Partner(s) Production, Imaging and MOST IMPORTANTLY!!! Research. Always looking deeper. RIP Dr. Thorpe
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.